Founded in 2015, BioSymetrics is a biomedical AI company that’s empowering healthcare and R&D innovation with leading data science expertise. Our work is focused on making end-to-end machine learning accessible to scientists and life sciences organizations.
The BioSymetrics technology offering is a SaaS-based biomedical Machine Learning (ML) platform, Augusta™, that enables customers to perform automated ML and data pre-processing. Augusta’s automated iteration framework addresses the step in ML that is the most time consuming and error-prone, that of cleaning and pre-processing unstructured data for analysis.
BioSymetrics serves biopharmaceutical, precision medicine, and technology companies, and hospitals and health systems. Augusta™ performs member-level predictive analytics on many kinds of R&D and healthcare data.
Our technology platform can work from raw data formats, applies robust feature selection methods, and conducts integrated analytics on siloed data and complex data types. Augusta can be GPU-implemented and Apache Spark distributed, and also incorporates “one-pass” ML to power enterprise or cloud solutions.